FHI 360

FHI 360 logo
🇿🇲Zambia
Ownership
Private
Established
1971-01-01
Employees
1K
Market Cap
-
Website
http://www.fhi360.org

FEM-PrEP (Truvada®): Study to Assess the Role of Truvada® in Preventing HIV Acquisition in Women

Phase 3
Completed
Conditions
Interventions
First Posted Date
2008-02-28
Last Posted Date
2018-07-26
Lead Sponsor
FHI 360
Target Recruit Count
2120
Registration Number
NCT00625404
Locations
🇿🇦

Josha Research Center, Bloemfontein, South Africa

🇿🇦

Setshaba Research Centre, Pretoria, Gauteng, South Africa

🇹🇿

Arusha Clinic, Levolosi Health Center, Arusha, Tanzania

and more 1 locations

A Randomized Controlled Trial of Three Vasectomy Techniques

Not Applicable
Terminated
Conditions
Interventions
First Posted Date
2008-02-12
Last Posted Date
2013-09-10
Lead Sponsor
FHI 360
Registration Number
NCT00612833
Locations
🇮🇳

St. Stephens Hospital, New Delhi, Delhi, India

🇮🇳

Maulana Azad Medical College, New Delhi, Delhi, India

🇮🇳

Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India

and more 2 locations

Continuous Use of COCs

First Posted Date
2007-12-11
Last Posted Date
2011-10-31
Lead Sponsor
FHI 360
Target Recruit Count
362
Registration Number
NCT00570440
Locations
🇩🇴

PROFAMILIA - Santo Domingo, Dominican Republic, Ens. Luperon, Santo Domingo, Dominican Republic

🇳🇮

PROFAMILIA - Managua, Nicaragua, Managua, Nicaragua

Madagascar Female Condom Study

Phase 3
Completed
Conditions
First Posted Date
2006-01-09
Last Posted Date
2006-01-09
Lead Sponsor
FHI 360
Target Recruit Count
1000
Registration Number
NCT00272974
Locations
🇲🇬

Dispensaire Kelly, Tamatave, Madagascar

🇲🇬

Isotry Health Center, Antananarivo, Madagascar

Use of Ibuprofen to Prevent IUD Site Effects

Phase 3
Completed
Conditions
First Posted Date
2005-10-25
Last Posted Date
2006-10-17
Lead Sponsor
FHI 360
Target Recruit Count
2019
Registration Number
NCT00243815
Locations
🇨🇱

43 Ministry of Health facilities, Santiago, Chile

Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV

Phase 2
Completed
Conditions
First Posted Date
2005-07-22
Last Posted Date
2006-08-01
Lead Sponsor
FHI 360
Target Recruit Count
1200
Registration Number
NCT00122486
Locations
🇨🇲

Care and Health Program, Douala, Cameroon

🇳🇬

University of College Hospital, Ibadan, Nigeria

🇬🇭

Virtual Access, Tema, Ghana

Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV

Phase 2
Terminated
Conditions
First Posted Date
2005-07-22
Last Posted Date
2006-02-10
Lead Sponsor
FHI 360
Target Recruit Count
500
Registration Number
NCT00122512
Locations
🇲🇼

UNC Project, Kamuzu Central Hospital, Lilongwe, Malawi

Cellulose Sulfate (CS) Gel and HIV in Nigeria

First Posted Date
2005-07-19
Last Posted Date
2007-02-28
Lead Sponsor
FHI 360
Target Recruit Count
2160
Registration Number
NCT00120770
Locations
🇳🇬

University of Port Harcourt Teaching Hospital, Center 10152, Port Harcourt, Nigeria

🇳🇬

Lagos University, College of Medicine, Center 10151, Lagos, Nigeria

© Copyright 2024. All Rights Reserved by MedPath